| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | -66.9% |
| R&D Expense | $76.8M | +10.2% |
| SG&A Expense | $41.7M | +36.6% |
| Operating Income | -$112.6M | -38.9% |
| Net Income | -$109.9M | -35.9% |
| EPS (Basic) | -$2.44 | -6.6% |
| EPS (Diluted) | -$2.44 | -6.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.1M | -0.9% |
| Current Assets | $207.5M | -8.2% |
| Total Assets | $226.7M | -3.5% |
| Current Liabilities | $16.7M | -12.9% |
| Total Liabilities | $27.7M | +18.3% |
| Stockholders' Equity | $198.9M | -6.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.0M | -23.7% |
| Capital Expenditures | $2.0M | +14.6% |
| Investing Cash Flow | $12.4M | +109.6% |
| Financing Cash Flow | $84.3M | -54.8% |
| Free Cash Flow | -$99.0M | -23.5% |